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A fine balance between cell survival and cell death is required to sculpt the
nervous system during development. However, an excess of cell death can occur
following trauma, exposure to neurotoxins or alcohol, and some developmental and
neurodegenerative diseases, such as Alzheimer’s disease (AD). N-Methyl-D-aspartate
receptors (NMDARs) support synaptic plasticity and survival of many neuronal populations
whereas inappropriate activation may promote various forms of cell death, apoptosis,
and necrosis representing the two extremes of a continuum of cell death processes
both “in vitro” and “in vivo.” Hence, by identifying the switches controlling pro-survival
vs. apoptosis and apoptosis vs. pro-excitotoxic outcome of NMDAR stimulation, NMDAR
modulators could be developed that selectively block the cell death enhancing pro-survival
signaling or synaptic plasticity mediated by NMDAR. Among these modulators, a role
is emerging for the enzyme serine racemase (SR) that synthesizes D-serine, a key
co-agonist with glutamate at NMDAR. This review summarizes the experimental evidence
from “in vitro” neuronal cultures—with special emphasis on cerebellar granule neurons
(CGNs)—and “in vivo” models of neurodegeneration, where the dual role of the
SR/D-serine pathway as a master regulator of apoptosis and the apoptosis-necrosis shift
will be discussed.
Keywords: serine racemase, D-serine, neurodegeneration, apoptosis-necrosis shift, NMDAR, neurological
disorders, review
INTRODUCTION
Cell death is an obligatory process in the development, mainte-
nance, and plasticity of the nervous system, and both anti-death
and pro-death modulators are key elements in designing neural
architecture. Conversely, the dysregulation of mechanisms con-
trolling cell death machinery activation can cause developmental,
neoplastic, and neurodegenerative disorders.
Cell death can manifest in many forms, which can be dis-
tinguished by various histological criteria “. . . (apoptosis, necro-
sis, autophagy), enzymological criteria (with and without the
involvement of nucleases or of distinct classes of proteases, such as
caspases, calpains, cathepsins, and transglutaminases), functional
aspects (programmed or accidental, physiological or patholog-
ical) or immunological characteristics (immunogenic or non-
immunogenic). . . .” (Kroemer and Galluzzi, 2009). However, in
many pathological conditions and in in vitro and in vivo disease
models, neuronal demise may result from complex, intersect-
ing, and merging fatal pathways (Jellinger, 2001; Andorfer et al.,
2005; Canu et al., 2005) that often imply the shift of one par-
ticular mode of cell death to another (e.g., apoptosis/necrosis
or necrosis/apoptosis shift), possibly via intermediate types of
cell death. Such complexity holds implications for the subse-
quent fate of the tissue because inhibiting a particular mechanism
renders the brain vulnerable to alternative death modes (Puyal
et al., 2013). Hence, by identifying switches between different
types of cell death modulators able to block selectively a specific
death pathway without causing the concomitant emergence of
alternative pathways could be developed.
Death signals are spatially and temporally segregated in neu-
rons, for example, at remote synaptic sites (Mattson et al., 1988;
Berliocchi et al., 2005). Indeed, much of the biochemical machin-
ery involved in apoptosis can be activated in synaptic terminals,
where it can remodel synapses or alter synaptic function and pro-
mote localized degeneration of synapses and neurites under both
physiological and pathological conditions. For example, caspase-
3 is crucially involved in monitoring, locally, protein levels in
retinal growth cone formation (Campbell and Holt, 2003), and
NMDAR-dependent caspase-3 activity is required for memory
storage in long-term depression (LTD) and AMPA receptor inter-
nalization in hippocampal neurons (Li et al., 2010). In a similar
way, the ubiquitin–proteasome system (UPS) is implicated in
apoptosis (Canu et al., 2000; Sun et al., 2004), synaptic strength,
homeostatic plasticity, axon guidance, and neurite outgrowth
(Hamilton and Zito, 2013).
The relevance of spatially and temporally segregated death
programs has also been confirmed by studies in neurodegener-
ative models, where a stage of synaptic dysfunction (for example,
electrophysiological deficits), microanatomical changes (such as
neurite retraction and synapse loss) (D’Amelio et al., 2011),
and cognitive deficits may precede neurodegeneration. Hence,
early perturbation of synapse integrity or function has been sug-
gested to be even more relevant than late neuronal loss in slow
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degenerative disorders (reviewed in Gillingwater and Wishart,
2013), such as Alzheimer (AD) (Davies et al., 1987; Sze et al.,
1997; Hatanpää et al., 1999; Mota et al., 2014); Huntington (HD)
(Mangiarini et al., 1996; Yamamoto et al., 2000), and Parkinson
diseases (PD) (Paumier et al., 2013) or in psychiatric disorders
such as schizophrenia (Faludi and Mirnics, 2011) where neuronal
loss is subtle, thus suggesting that loss of neurites and synaptic
dysfunction may define the hystopathological phenotype of AD,
HD, PD, or schizophrenia.
Death programs are activated with extraordinarily repro-
ducible patterns in specific nuclei and with specific frequencies at
particular times of nervous system development. However, they
may also be inappropriately activated by various insults, such as
trophic factor withdrawal, altered NMDAR stimulation, excito-
toxicity, misfolded proteins, reactive oxygen and nitrogen species,
mitochondrial-complex inhibition, calcium entry, death-receptor
activation, etc.
Here, NMDAR represents the main neuronal, specific signal-
ing system that bidirectionally regulates cell fate by stimulat-
ing pro-survival or pro-death signaling; the latter share many
common intracellular signal pathways with NMDAR-dependent,
long-term potentiation (LTP) and LTD, respectively (Bartlett and
Wang, 2013). NMDAR may decide whether, when, and how neu-
rons die. Both hypofunction and overstimulation of NMDAR can
cause cell death. Blockade of NMDAR elicits apoptosis, while
overstimulation of NMDAR can trigger either apoptosis or necro-
sis, depending on the intensity of receptor activation (Bonfoco
et al., 1995; Staton and Bristow, 1997). Precisely, short exposure
to low concentrations of glutamate or NMDA evokes apoptosis
in cortical neurons (Leist et al., 1999), whereas intense expo-
sure to high concentrations of NMDA or glutamate induces
necrotic cell damage (Bano et al., 2005). In this latter case, the
degree of cell loss depends on the magnitude and duration of
synaptic and extrasynaptic NMDAR coactivation (Zhou et al.,
2013).
Unlike other neurotransmitter receptors, the simultaneous
binding of two co-agonists, glutamate and glycine or D-serine,
with different biophysical properties of ion permeation is
required to activate NMDAR (Johnson and Ascher, 1990). The
continuous (i.e., nonsynaptically released) presence of D-serine
or glycine is an absolute prerequisite for both NMDAR activity
during normal neurotransmission and NMDAR overstimula-
tion that occurs in various neurological disorders (Kleckner and
Dingledine, 1988; Danysz and Parsons, 1998).
D-serine is synthesized from L-serine by glial and neuronal
enzyme serine racemase (SR, EC 5.1.1.18) (De Miranda et al.,
2002) (Figure 1) and is selectively degraded by both SR and the
peroxisomal D-amino acid oxidase (DAAO, EC 1.4.3.3) (Sacchi
et al., 2012). Thus, it is not surprising that D-serine and the
enzymes involved in its metabolism are crucially involved in sev-
eral physiological and pathological processes related to NMDAR
function and dysfunction.
The present review focuses on how activation of a death pro-
gram implies that the SR-D-serine pathway is modulated and
how this, in turn, contributes to the cell death phenotype. Firstly,
the role of NMDAR on survival and cell death will be briefly
reviewed. Secondly, the biology and regulation of SR will be
widely analyzed. Thirdly, results—from a cerebellar granule neu-
ron (CGN) in vitro model of apoptosis—suggesting that the
SR-D-serine pathway can be modulated by apoptosis to execute
the death program and to channel neurons to a necrotic pheno-
type will be presented and discussed. Finally, different disease-
related brain dysfunctions associated with altered SR expression
will be presented and discussed in relation to death program
activation and altered NMDAR activity.
NMDA RECEPTORS
Normal physiological brain function and neuronal survival
require adequate activation of NMDARs. These receptors are
glutamate-gated ion channels composed of different subunits
with differing biophysical and pharmacological properties, inter-
acting partners, and subcellular localization (Paoletti et al., 2013;
Sanz-Clemente et al., 2013). NMDAR subunits are classified into
three subfamilies: one NR1 subunit (constituted by 8 splice vari-
ants), four NR2 subunits (2A, 2B, 2C, and 2D), and two NR3
subunits (3A and 3B) (Traynelis et al., 2010). All NMDARs com-
prise two NR1 subunits and two copies of NR2 and/or NR3
subunits: the latter two copies can be identical or different, thus
yielding di-heteromeric and tri-heteromeric receptors, respec-
tively, which may be present in various areas of neuronal plasma
membrane (synaptic and extrasynaptic).
Molecular mechanisms controlling subunit-specific NMDAR
function include developmental regulation of subunit transcrip-
tion/translation, differential trafficking through the secretory
pathway, post-transcriptional modifications (i.e., phosphoryla-
tion), and protein-protein interactions (Sanz-Clemente et al.,
2013). Due to the early expression in development, the N2B, 2D,
and N3A subunits are important for synaptogenesis and synap-
tic maturation (Henson et al., 2010), while in the adult forebrain,
synaptic NMDARs are largely di-heteromeric NR1/NR2A and tri-
heteromeric NR1/NR2A/NR2B receptors. Peri- and extrasynaptic
sites are enriched in NR2B-containing receptors (Hardingham
and Bading, 2010).
NMDAR subunits consist of four domains: two large glob-
ular bilobate domains in the extracellular region, comprising
the N-terminal domain (which is involved in subunit assem-
bly and allosteric regulation) and the agonist-binding domain
(which binds the primary agonist glutamate in NR2 subunits
and coagonist glycine or D-serine in NR1 and NR3 subunits);
the transmembrane domain composed of three transmembrane
helices and a pore loop that lines the ion selectivity filter; and a
long intracellular C-terminal domain (which is involved in recep-
tor trafficking, anchoring, and coupling to signaling molecules);
reviewed in Paoletti et al. (2013).
The subunit composition of NMDARs is modified during
development in response to neuronal activity or sensory expe-
riences (Henson et al., 2010); plasticity can also develop at
adult synapses. Various mechanisms may be responsible for the
NR2B-to-NR2A subunit modification: (i) novel receptors are
inserted through trafficking from the endoplasmic reticulum;
(ii) existing synaptic receptors are removed through endocyto-
sis; and (iii) clearance of fast-moving, NR2B-containing recep-
tors from synaptic sites through lateral diffusion (Groc et al.,
2006). Owing to the mobility of NMDAR between synaptic and
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FIGURE 1 | Reactions catalyzed by serine racemase: (A) racemization; (B)
α, β-elimination. Lys56 of SR binds the PLP cofactor, forming an internal
aldimine; then SR reacts with L-serine to yield an external aldimine; α-proton
abstraction from this intermediate gives a resonance-stabilized carbanion.
Two alternative pathways are possible starting from this intermediate (see
text for details).
extrasynaptic sites, receptor number and subunit composition are
finely regulated.
Using specific enzymes that degrade D-serine or glycine—
Rhodotorula gracilis D-amino acid oxidase or Bacillus subtilis
glycine oxidase (Pollegioni et al., 1993; Fantinato et al., 2001;
Job et al., 2002)—and electrophysiological recordings in the CA1
region of the hippocampus (largely populated by NR2A recep-
tors which have a better affinity for D-serine than for glycine),
evidence was provided that D-serine is the coagonist at synap-
tic NMDARs, whereas glycine is the coagonist at extrasynaptic
NMDARs (Papouin et al., 2012). This functional compartmental-
ization arises from glycine and D-serine availability and matches
the preferential affinity of NMDARs for these two coagonists.
Indeed, glycine strongly and rapidly inhibits the mobility of
NR2A-NMDARs, whereas D-serine preferentially slows down
the lateral diffusion of NR2B-containing receptors. Finally, it
was demonstrated that LTP and NMDA-mediated excitotoxic-
ity depend on synaptic NMDARs, whereas LTD requires both
synaptic and extrasynaptic receptors.
A weakening in memory function with aging is often linked
to impaired synaptic plasticity, which might arise from altered
function and/or expression of NMDARs (i.e., the NR2B sub-
unit): recovery of NMDAR decline is known to improve LTP
(Magnusson et al., 2010). The recent recognition that NMDAR
subunit composition can be remodeled according to activity, even
in adults, further supports the notion that the molecular compo-
sition of the receptor is tailored to match the needs of specific
neural functions.
NMDAR IN SURVIVAL AND CELL DEATH
Both NMDAR hypofunction and NMDAR hyperactivity (exces-
sive Ca2+ influx through NMDARs) induce neuronal death and
are deleterious (Sanz-Clemente et al., 2013).
The first hint that NMDAR supports neuronal survival came
from the findings that cultured rat CGNs survived in the pres-
ence of depolarizing concentrations of KCl (Gallo et al., 1987).
Given that this condition was suggested to mirror the afferent
glutammatergic inputs received by the CGNs in vivo (Borsello
et al., 2000), it was hypothesized that NMDAR signaling ensures
survival of newly generated granule neurons. It was then shown
that NMDAR activation by exogenous NMDA prevented rat CGN
survival from decreasing under low KCl concentrations (Balázs
et al., 1988, 1989) by inhibiting programmed cell death (PCD)
induced by low potassium levels (Yan et al., 1994; Alavez et al.,
2006; Xifró et al., 2006; Bazán-Peregrino et al., 2007; Jantas and
Lason, 2009; Esposito et al., 2012). Then, it was reported that
NMDA offered protection to other neuronal populations in vitro,
such as rat cortical neurons, subjected to several apoptotic stim-
uli, including serum deprivation and treatment with NMDAR
antagonists or PI-3 kinase inhibitors (Hetman et al., 2000; Terro
et al., 2000). Similarly, NMDAR antagonists elicited apoptosis
in cortical and retinal neurons in culture (Hwang et al., 1999;
Takadera et al., 1999), worsened rat cortical neuron apopto-
sis induced by serum deprivation (Hetman et al., 2000; Terro
et al., 2000), and caused a marked decrease in the number of
dopaminergic neurons in P2-P3 rat midbrain slice (Katsuki et al.,
2003). Transient blockade of the NMDAR during prenatal or
early neonatal life has been shown to trigger death in multiple
developing forebrain structures (Gould et al., 1994; Ikonomidou
et al., 1999). These findings were also confirmed in primates,
where prenatal blockade of NMDAR by antagonists, anesthet-
ics, or substances of abuse compromise neuronal survival during
brain development.
The apoptotic responses to decreased NMDAR activity during
the critical period of synapse formation suggests that NMDAR
supports survival of those neurons that have established appro-
priate synaptic connections (Adams et al., 2004). Thereafter, the
contribution of NMDAR to survival decreases. Indeed, NMDAR
hypofunction or blockade in adult brain does not cause cell
death, but rather damages the synapses, for example, by alter-
ing NMDAR subunit trafficking into dendritic spines (Aoki et al.,
2003), decreasing dendritic spine density (Velázquez-Zamora
et al., 2011), or impairing function and altering the morphology
of dendritic spines, as in medium spiny neurons of corticostriatal
slices treated with NR2A antagonist (Vastagh et al., 2012), which
renders neurons more vulnerable to neurodegeneration.
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On the other hand, overactivation of NMDARs reduces brain
cell survival signals and disrupts brain function, causing neu-
rotoxicity through calcium dysregulation and oxidative stress.
Hyperactivation of NMDAR is a major cause of cell death fol-
lowing acute neuronal injury, such as stroke and trauma, and is
also implicated in neurodegenerative diseases, such as PD, HD,
and late AD (Hardingham and Bading, 2003).
NMDAR-mediated pro-survival activity is, in part, medi-
ated through the suppression of pro-apoptotic kinases, such
as glycogen synthase kinase 3 beta (GSK-3β), and the activa-
tion of survival signaling kinases, including the extracellular
signal-regulated kinases (ERK1/2), the serine/threonine protein
kinase B (Akt, also known as PKB), and Ca2+/calmodulin-
dependent protein kinase II/IV (CamKII/IV) that converge on
cAMP responsive element-binding protein (CREB) to activate
pro-survival genes (Hetman and Kharebava, 2006). NMDAR-
mediated toxicity triggers an excessive entry of Ca2+, which initi-
ates a series of cytoplasmic and nuclear processes that promote
neuronal cell death, such as CREB shut-off signaling; activa-
tion of Ca2+-activated proteolytic enzymes (e.g., calpains that
degrade cytoskeleton proteins and Na+Ca2+ channel exchanger);
and increased levels of phospho c-Jun N-terminal kinases
(pJNK), phospho p38 kinase, and nitric oxide synthase (NOS)
(Figure 2).
SERINE RACEMASE
GENERAL PROPERTIES
Mammalian SR is a pyridoxal-5′ phosphate (PLP)-containing
enzyme that was isolated at the end of the last millennium from
rodent brain by Snyder’s group (Wolosker et al., 1999). SR was
identified for its ability to catalyze the racemization of L-serine to
D-serine (Figure 1A) although, subsequently, SR has been shown
to catalyze α,β-elimination of water from L- or D-serine to yield
pyruvate and ammonia (Figure 1B) (De Miranda et al., 2002;
Foltyn et al., 2005; Pollegioni and Sacchi, 2010; Campanini et al.,
2013).
The first observation that SR catalyzes an α,β-elimination reac-
tion with L-serine was demonstrated in cells transfected with SR
since they produced high levels of pyruvate along with D-serine
(De Miranda et al., 2002): the pyruvate/D-serine ratio was ≈4,
indicating that the α,β-elimination reaction predominates over
the racemization. In contrast, little or no pyruvate was produced
from L-serine by preparing purified SR: the recombinant enzyme
lacks essential cofactor(s), later on identified as Mg-ATP. Since
ADP is also equally effective in SR activation, it was argued that
the role of ATP is not related to an energy requirement for enzyme
activity.
Both the racemization and elimination reactions from L-serine
were activated up to 10-fold by >10μM MgCl2/CaCl2 and by
FIGURE 2 | Scheme illustrating the main pro-survival and pro-death signals triggered by NMDAR activity.
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>100μM ATP (interestingly, Mg2+ and ATP modulate SR activ-
ity at concentrations below those found in the cytosol) (Cook
et al., 2002; De Miranda et al., 2002). Mg2+ or Ca2+ cations
interact with similar affinity to a specific site: the former should
represent the physiological ligand since the free Mg2+ concentra-
tion in the cells is several orders of magnitude higher than Ca2+.
The racemase activity was independently stimulated by both
Mg2+ and ATP: the nucleotide increased SR activity even in the
presence of EDTA, and the effect due to divalent ion and ATP was
additive (De Miranda et al., 2002). In the presence of 1mM ATP,
the Km for L-serine is decreased 10-fold with little change in Vmax
(Neidle and Dunlop, 2002). EDTA impairs the α,β-elimination
reaction, which is instead stimulated by 100μM Mg2+ in the
absence of exogenous ATP or by 10μM of divalent ion in the
presence of the nucleotide (De Miranda et al., 2002; Foltyn et al.,
2005). Very recently, Mozzarelli’s group demonstrated a cross-
talk between the allosteric and active sites in SR, leading to the
stabilization of two alternative protein conformations with ATP
affinities of ∼10μM and 1.8mM. In fact, the dependence of
α,β-elimination and L-serine racemization activities on ATP con-
centration was strongly cooperative (Hill coefficients ∼2), as was
ATP binding to the holoenzyme. The active site ligand glycine
increased the SR affinity for ATP by 22-fold and abolished coop-
erativity while ATP increased the noncooperative glycine binding
15-fold (Campanini et al., 2013; Marchetti et al., 2013).
A review of the morphology, gene expression, neurotransmis-
sion/neurodegeneration, and behavior of SR knockout mice was
recently published (Wolosker and Mori, 2012).
CATALYTIC MECHANISM
Sequence and structural analyses indicate that SR belongs to the
fold type II group of PLP-dependent enzymes, together with
many other racemases and dehydratases. The recent determina-
tion of the crystal structure of the Saccharomyces pombe homolog
(pdb code 1WTC) (Goto et al., 2009) followed by the rat and
human SR (pdb code 3L6B and 3HMK, respectively) (Smith et al.,
2010) has given us a deeper understanding of SR catalytic mech-
anism and the location of the cofactor binding sites (Figure 3).
The enzyme is a homodimer, each monomer (340 amino acids)
consisting of two domains, a small and a large domain connected
by a flexible loop (Goto et al., 2009; Smith et al., 2010). The
large domain contains most of the residues that interact with PLP
(Lys56 that forms the Schiff base with PLP during catalysis is con-
served in PLP-containing racemases) and the residues involved
in the dimerization; the site for binding of Mg-ATP is located
at the interface between the domains, outside the catalytic site
(Figure 3).
It has been proposed that binding of L-serine to SR in complex
with Mg-ATP alters the enzyme conformation from an open to a
closed form (Goto et al., 2009). During this reorientation of the
small and large domains, the small domain is likely to reposition
itself toward the catalytic site and orient Ser84 toward the sub-
strate (Smith et al., 2010). Mg2+ is coordinated by the carboxylic
groups of Glu210 and Asp216 and the backbone carbonyl oxygen
of Ala214 (Goto et al., 2009; Smith et al., 2010).
Mechanicistically, the racemization and α,β-elimination
reactions share the same intermediate, represented by a
FIGURE 3 | Dimeric structure of human SR and details of the active
site. PLP is shown in orange, malonate in red, and Mn2+ as red sphere.
resonance-stabilized carbanion (Figure 1): this intermediate
forms a partition between the two pathways. L-Serine binds to
PLP, yielding an external aldimine intermediate, followed by
the abstraction of the α-proton by Lys56 and formation of a
planar resonance-stabilized carbanion (Foltyn et al., 2005). At
this point, protonation in the opposite side of the carbanion
intermediate (mediated by the Ser84-OH group) (Goto et al.,
2009; Smith et al., 2010) generates D-serine (racemization
reaction). Since the proton abstraction and the reprotonation
steps are performed by different residues (Lys56 and Ser84) that
work as acid/base catalysts, SR racemization is consistent with
a two-base mechanism. In the α,β-elimination reaction, proto-
nation of the β-hydroxy group of the substrate eliminates water
from the carbanion intermediate and an unstable aminoacrylate
intermediate is formed, followed by release of iminopyruvate
and spontaneous hydrolysis into pyruvate and NH4+ (Figure 1).
The partition between the elimination of the β-hydroxyl group
and racemization (reprotonation on αC) is affected by Mg-ATP,
which favors the former (Foltyn et al., 2005).
Mouse SR activity is inhibited by amino acids contain-
ing –SH groups (cysteine and homocysteine) or electron-
withdrawing groups on the β-carbon of alanine (β-haloalanine):
these compounds react with PLP to yield thiazolidine derivatives.
Most interestingly, L-aspartate and glycine are also competitive
inhibitors of SR (Ki is 1.9 and 0.15mM, respectively), indicating
that their in vivo concentration plays a role in D-serine synthe-
sis (i.e., glycine concentration in astrocytes is in the 3- to 6-mM
range) (Dunlop and Neidle, 2005). Several dicarboxylic acids are
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strong, competitive inhibitors of SR (Strísovský et al., 2005), but
so far, no selective enzyme inhibitors have been discovered. The
most potent known SR inhibitor is L-erythro-3-hydroxyaspartate
(Ki = 49μM), which competes with L-serine (Strísovský et al.,
2005).
PHYSIOLOGICAL ROLE OF α,β-ELIMINATION
The physiological role of SR is probably different in different tis-
sues. In the liver, a tissue lacking NMDAR, pyruvate generated
by the α,β-elimination reaction catalyzed by SR should play a
metabolic role: SR is located in neuronal processes, where it might
significantly contribute to the metabolic demands (Kartvelishvily
et al., 2006). On the other end, the SR-catalyzed α,β-elimination
reaction provides an unusual mechanism for controlling intra-
cellular D-serine levels in the brain, particularly in the forebrain,
where SR expression is highest and the D-serine catabolic enzyme
DAAO is poorly expressed.
In neurons, the steady-state levels of D-serine are largely mod-
ulated by SR activity: D-serine is produced from L-serine by
the isomerization reaction and is also constantly consumed by
the α,β-elimination reaction with a rate fast enough to limit
the achievable D-serine concentration in vitro and in intact cells
(Foltyn et al., 2005). Formouse SR, the elimination reaction start-
ing from L-serine possesses a 2-fold higher kinetic efficiency than
the racemization reaction (the Vmax/Km ratio is 20 and 12mM−1
min−1, respectively) and the racemization of D-serine into L-
isomer is 3-fold higher than for the pyruvate elimination reaction
(Strísovský et al., 2005; Table 1 in Pollegioni and Sacchi, 2010).
The presence of Mg-ATP stimulates D-serine degradation as
L-serine is consumed by the purified SR: under equilibrium con-
ditions, almost all L- and D-serine will be converted to pyruvate
and ammonia. The impact of α,β-elimination is best appreci-
ated when SR is exposed to a physiological L-serine/D-serine
ratio (1 and 0.3mM of L- and D-serine, respectively): the level
of both enantiomers decreases. In constrast, EDTA chelation of
divalent ions stabilizes D-serine by blocking the α,β-elimination
activity.
A list of the molecules known to modulate the activity of SR is
reported in Table 1.
PHYSIOLOGICAL REGULATION OF SR
SR is regulated by Grip1 (glutamate receptor interacting protein,
usually coupled to the Glu2/3 subunits of the α-amino-3-
hydroxy-5-methylisooxazole-4-propionic acid—AMPA-Ca2+
channel), which binds to the C-terminal region via its PDZ6
domain (Kim et al., 2005). Both mouse and human SR contain a
ValSerCys sequence at their C-terminus, a motif resembling the
type II consensus sequence for binding to PSD95/disc large/ZO-1
(PDZ) domains: SR is activated by binding to the PDZ6 domain
of Grip1. Full activation of SR requires binding to the remaining
part of the C-terminal region of GRIP (Baumgart et al., 2007).
SR also binds to the protein interacting with C kinase 1
(PICK1), a PDZ domain-containing protein proposed to regu-
late subcellular localization and membrane expression of var-
ious binding partners because of the interaction with lipid
membranes. Neonatal PICK1-deficient mice display 30% lower
D-serine levels in the forebrain, and HEK293 cells transfected
with SR or PICK1 (or both) show an increase in D-serine
concentration (Hikida et al., 2008).
SR is also modulated by Golga3, the Golgin subfamily A
member 3 that is associated with the cytosolic face of the Golgi
apparatus. SR is degraded through the UPS, and association of
the N-terminal 66 residues of SR with Golga3 decreases SR pro-
tein degradation and increases D-serine synthesis (Dumin et al.,
2006). Golga3 and SR colocalize in the cytosol perinuclear Golgi
region and in neuronal and glia processes in primary cultures;
SR strongly bound to the membrane constitutes a pool of avail-
able SR to be exported/targeted to different cell compartments
(Dumin et al., 2006).
Interestingly, SR is regulated by glutamate receptors via multi-
ple mechanisms by modulating SR interaction with membranes.
Binding of SR to the membrane is regulated by NMDAR acti-
vation and interaction with phosphatidylinositol lipids (Balan
et al., 2009; Mustafa et al., 2009). In primary rat neuronal cul-
tures, NMDAR activation promotes translocation of SR from
the cytosol to dendritic membranes, a process that dramatically
decreases SR activity and thus D-serine synthesis. Such a translo-
cation requires palmitoylation of SR at the serine/threonine
residues and the phosphorylation at Thr227 (Balan et al., 2009).
This inhibition of SR should represent a reliable strategy to
prevent NMDAR overactivation in vicinal cells or synapses.
Indeed, SR is also inhibited via the glial cell membrane by
phosphatidylinositol(4,5)-bisphosphate (PIP2) (Mustafa et al.,
2009). Degradation of PIP2 by metabotropic glutamate receptor
activation releases SR from the membrane and thus SR recovers
the activity (Mustafa et al., 2009).
By using the U87 human glioblastoma cell line, SR activity
was also demonstrated to be inversely regulated by D-serine and
nitric oxide: SR activity was enhanced in a dose-dependent man-
ner by D-serine and was inhibited by NO (Shoji et al., 2006a).
Indeed, D-serine induces the denitrosylation of SR. Interestingly,
DAAO activity was enhanced by NO in a dose-dependent man-
ner (Shoji et al., 2006b). It was suggested that NMDAR-mediated
Ca2+ influx at postsynaptic neurons involves Ca2+/calmodulin-
dependent activation of neuronal NO synthase: the NO produced
here diffuses into adjacent astrocytes or neurons to nitrosylate
and inhibit SR and activate DAAO (Shoji et al., 2006a,b). Cys113,
identified as the target residue of SR nitrosylation, is in close prox-
imity to the ATP-binding region and thus nitrosylation might
displace ATP from its binding site and inactivate SR: ATP and NO
reciprocally activate and inhibit the enzyme by acting at the same
protein site (Mustafa et al., 2007).
A list of the molecules known to modulate the activity or
stability of SR is reported in Table 1.
LOCALIZATION
Human SR mRNA was mainly identified in brain, heart, skele-
tal muscle, kidney, and liver tissues (Xia et al., 2004; Yamada
et al., 2005). It mainly localized in brain areas containing high
levels of endogenous D-serine (i.e., hippocampus and corpus
callosum) with intermediate levels in substantia nigra and cau-
date and negligible levels in brainstem. Multiple protein bands of
human SR were observed byWestern blot analysis: a 39-kDa band
was apparent in HEK293-transfected cells, a band at 42 kDa in
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Table 1 | Known modulators of SR (activity and stability).
POSITIVE EFFECTS
MgCl2/MnCl2 Increase in activity at >10μM De Miranda et al., 2002
ATP Increase in activity at >100μM; change in Km for L-serine De Miranda et al., 2002; Neidle and Dunlop, 2002
Increase in glycine binding Marchetti et al., 2013
Glycine Increase in ATP affinity Marchetti et al., 2013
Grip1 Activation by interaction through PDZ domain Kim et al., 2005; Baumgart et al., 2007
PICK1 Activation by interaction through PDZ domain Hikida et al., 2008
Golga3 Protection from protein degradation Dumin et al., 2006
NEGATIVE EFFECTS
Cysteine, homocysteine, β-haloalanine Inactivation by PLP modification Dunlop and Neidle, 2005
L-aspartate Competitive inhibitor, Ki = 19mM Dunlop and Neidle, 2005
Glycine Competitive inhibitor, Ki = 0.15mM Dunlop and Neidle, 2005
L-herythro-3-hydroxyaspartate L-serine competitive inhibitor, Ki = 0.049mM Strísovský et al., 2005
EDTA Metal chelation, block of α,β-elimination Strísovský et al., 2005
Phosphotidylinosityl lipids Inhibition by palmitoylation and phosphorylation Balan et al., 2009
Nitric oxide Inhibition by nitrosylation (reversed by D-serine) Shoji et al., 2006a
human brain extracts, and a band at 62 kDa in kidney and heart,
where an additional 80-kDa band was also apparent (Xia et al.,
2004). SR was initially localized in astrocytes while subsequent
studies showed a predominantly neuronal localization; neurons
represent the cells from which D-serine is released upon mem-
brane depolarization (Kartvelishvily et al., 2006; Wolosker et al.,
2008).
During postnatal development in the brain, SR is localized
in glutamatergic neurons in the cerebral cortex and in the glu-
tamatergic pyramidal neurons of the hippocampus, where it is
mainly present at postsynaptic sites. In the adult cerebellum,
levels of SR expression are lower than those reported for the
telencephalic regions; a weak SR expression was also apparent
in GABAergic Purkinje cells (Miya et al., 2008). These find-
ings suggest that SR is expressed in principal neurons of given
neuronal regions, irrespective of the excitatory or inhibitory sig-
nature. Furthermore, SR was also identified in samples from
the perireticular nucleus, a transient structure of developing
brain in humans, pointing to the importance of SR function
for developing correctly formed corticothalamic and thalamo-
cortical connections by stimulating D-serine-dependent NMDAR
activity.
It is noteworthy that synthesis of both neuronal and astrocytic
D-serine in the brain is dependent on 3-phosphoglycerate dehy-
drogenase, an enzyme that occurs mainly in astrocytes and which
catalyzes the first step in L-serine biosynthesis: L-serine shuttles
from astrocytes into neurons where it is transformed by neuronal
SR to D-serine (Ehmsen et al., 2013).
THE SERINE RACEMASE-D-SERINE-RELATED PATHWAY IN
NEURONAL APOPTOSIS
Although our knowledge of the mechanisms underlying neuronal
cell death is far from complete, research on rodent and human
models has identified factors regulating NMDAR activation and
signaling as being a component of neuronal demise.
Apoptosis, a type of PCD, is a genetically directed process
that involves a controlled sequence of steps in which cells signal
self-destruction. It is activated either by the presence of a stimu-
lus or removal of a suppressing agent or stimulus and constitutes
a normal physiological process of eliminating DNA-damaged,
superfluous, or unwanted cells without damaging neighboring
cells or eliciting an inflammatory response. Such a complex pro-
cess, which occurs in an orderly manner, is characterized by
specific biochemical (caspase and calpain activation) and mor-
phological events (DNA fragmentation, neurite retraction, and
membrane blebbing). It depends on the activity of an integrated
network of genes, regulated at both the transcriptional and post-
transcriptional level. In particular, changes in the balance of pro-
and anti-apoptotic factors determine whether cells die or survive.
The involvement of SR in physiological NMDAR activity and
its crucial contribution to NMDAR overactivaction in many
pathological settings has been widely documented. We, for the
first time, have investigated whether the induction of the apop-
totic program in a neuronal population—strongly dependent on
NMDAR signaling for their survival and proper differentiation—
induced a change in the enzymes related to D-serine metabolism,
mainly SR (Esposito et al., 2012).
Cerebellar granule cell cultures are very useful for studying
mechanisms involved in apoptosis and excitotoxic cell damage
as they contain a relatively homogeneous population of neu-
rons and are known to express different glutamate receptors. In
a serum-based medium containing an inhibitor of mitosis and
a high concentration of KCl (25mM), CGNs can be maintained
with high purity (95–98%). Under these conditions the propor-
tion of nonneuronal cells (astroglia and interneurons) is very low
(1–2%). CGNs undergo massive cell death when the depolariz-
ing potassium concentration normally employed for cell culture is
reduced from 25 (K25) to 5mM (K5). This manipulation, exper-
imentally compared to the surgical disconnection of the nerve
afferents to CGN (Borsello et al., 2000) taking place either dur-
ing embryogenesis or in various neurological diseases, activates an
internal program of PCD in which biochemical and morpholog-
ical elements of apoptosis and autophagy and UPS intersect and
influence each other (Canu et al., 2000, 2005). This apoptotic cell
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death mimics the naturally occurring death of 20–30% of gran-
ule cells, a process important for matching the number of granule
cells with Purkinje cells between the 3rd and 5th week postnatally
after granule migration, which is known to require SR activation
and D-serine release (Kim et al., 2005). Cell death evoked by K5 is
associated with DNA fragmentation and caspase activation and
requires both new RNA and protein synthesis (D’Mello et al.,
1993): in fact, addition of protein or RNA synthesis inhibitors
within the first 4 h of exposure to K5 prevents cell death and
results in a complete recovery of the damaged DNA (D’Mello
et al., 1993). However, the activation of the cell death program
becomes irreversible in ≈50% of CGNs after 6 h of exposure to
K5 (Nardi et al., 1997).
SERINE RACEMASE IS DOWNREGULATED DURING THE EARLY PHASE
OF APOPTOSIS
Time course studies have indicated that the level of SR protein
is modulated very early during CGN apoptosis, before signifi-
cant cell death. Interestingly, a biphasic expression pattern for SR
protein was observed, with a drastic drop in protein levels by 50
and 70% at 6 and 24 h after apoptosis induction, respectively, fol-
lowed by a secondwave of increased expression in the late phase of
apoptosis. Such SR changes were not observed in glial cells, which
account for only 1% of the total cells in culture (Esposito et al.,
2012). The finding that a decrease in SR protein in CGNs under-
going apoptosis was accompanied by a reduction in intracellular
D-serine levels gives support to the recent report that D-serine is
predominantly produced by neuronal cells (Ehmsen et al., 2013).
Interestingly, the decrease in SR protein was only reversed by
UPS inhibitors, JNK inhibitors, application of NMDA, and/or
D-serine. By contrast, inhibitors acting in the execution phase of
apoptosis were unable to prevent it, suggesting that the decline
in SR occurs in the commitment, transcription-dependent, phase
(Esposito et al., 2012). Signaling pathways known to be involved
in the control of neuronal survival are regulated during neu-
ronal apoptosis at the transcriptional level and not only by
post-translational mechanisms (Desagher et al., 2005). Similarly,
SR decline is likely due to reduced transcription, as SR mRNA
is rapidly downregulated after KCl deprivation via a pathway
dependent on UPS and JNK kinase. Concerning the mechanism
by which UPS and JNKs—two crucial players in CGN apoptosis
(Canu et al., 2000; Harris et al., 2002)—regulate SR expression,
we suggest that they likely act via mechanisms that could involve
c-Jun. c-Jun, whose expression and phosphorylation increases
rapidly after KCl withdrawal (Xifró et al., 2006), is known to
induce transcription of SR in microglia cells treated with beta
amyloid (Aβ) by JNK-dependent recruitment of AP-1 complex
(b-Jun-c-Fos) on SR intron 1c (Wu and Barger, 2004). It is
known that the AP-1 complex determines transactivation poten-
tial (Kaminska et al., 2000). Thus, we suggest that during neuronal
apoptosis JNK should reduce SR transcription through an AP-1
complex comprising ATF-2 and c-Jun, given that c-Fos is rapidly
downregulated during cerebellar apoptosis (Yuan et al., 2009).
However, post-transcriptional mechanisms may also contribute
to modulating SR expression. SR has a relatively short half-life
and UPS regulates its turnover in a Golga3-modulated manner;
see above (Dumin et al., 2006). It is conceivable that activation of
UPS in the early phase of apoptosis may degrade SR as well (Canu
et al., 2000). Further studies are needed to clarify the molecular
mechanisms that govern SR regulation during apoptotic events.
This has implications for SR downregulation under conditions
characterized by NMDAR hypofunction and apoptotic events.
For example, SR is downregulated in the nucleus accumbens of
rats treated with cocaine (Curcio et al., 2013), which is known
to be toxic for different cell types by increasing active caspase-3
and reactive oxygen species (Lepsch et al., 2009; Costa et al.,
2013), and during aging (Mothet et al., 2006; Turpin et al., 2011;
Billard, 2013), where neuronal cell loss has been attributed in part
to increased NO production and high caspase activity (Akbulut
et al., 2013).
WHY IS SERINE RACEMASE DOWNREGULATED DURING THE EARLY
PHASE OF NEURONAL APOPTOSIS?
The most obvious answer to this question is that the apop-
totic program implies that neuronal sensitivity to glutamate is
modulated and may thereby influence the mode of cell death,
preventing excitotoxic necrosis and ensuring apoptosis. One
possible mechanism by which apoptosis might modulate gluta-
mate responses is by affecting glutamate receptor subunits. For
example, in primary hippocampal neurons induced to undergo
apoptosis by staurosporine, caspase-3-mediated degradation of
AMPAR has been reported to be crucial for correctly driving neu-
rons down the apoptotic pathway preventing necrosis (Glazner
et al., 2000). In our model the situation is quite different since:
(a) levels of both AMPAR and NMDAR subunits NR1, NR2A,
and NR2B do not change after KCl deprivation (Canu, unpub-
lished data); (b) level of SR is unchanged in CGNs induced
to undergo apoptosis by staurosporine, suggesting that modula-
tion of SR expression by apoptosis is stimuli-dependent (Canu,
unpublished data); and (c) pharmacological inhibition of SR by
phenazine-metosulphate and shRNA-mediated suppression of SR
both exacerbate K5-death-inducing signaling.
Therefore, if apoptotic CGNs were decreasing the level of
SR (and of D-serine) to prevent necrosis, then it would be
expected that cell death would increase by adding D-serine to
neurons undergoing apoptosis. Actually, adding D-serine (50–
100μM) to medium of CGNs undergoing apoptosis (K5) or
overexpression of SR by adenovirus-mediated transduction does
not increase cell death, but rather helps CGNs recover from
apoptosis. Under both conditions, protection (which is NMDAR-
dependent since it is blocked by the concomitant addition of
5,7-dichlorokynurenic acid, DCKA, a selective NMDAR antag-
onist acting at the glycine site) involves prevention of Akt and
ERK1-2 dephosphorylation, JNK phosphorylation, and caspase
activation and caspase-mediated cleavage of tau protein.
Thus, by decreasing the level of D-serine, apoptotic neurons
avoid fully activating NMDAR and therefore stimulating survival
molecules such as Akt and ERK1-2, whose kinase activities have
been demonstrated to be critical in transmitting survival sig-
nals in this model of neuronal apoptosis (Shimoke et al., 1998;
Chin et al., 2004). Moreover, the apoptotic program ensures the
decrease in D-serine levels through the opposite regulation of SR
and DAAO. By microarray assay, we found that the DAAO gene is
significantly (2-fold) upregulated and that its activity is increased
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by +82, +170, and +90% at 1, 3, and 6 h of apoptosis, respec-
tively, compared to control nonapoptotic neurons (Esposito et al.,
2012). Moreover, the DAAO inhibitor sodium benzoate is able to
reduce D-serine decline and also increase survival (Canu, unpub-
lished data). The opposite regulation of the two main D-serine
metabolic enzymes has been reported under other experimental
conditions. DAAO and SR, when present in the same cells, do
not work in isolation; e.g., their activities are regulated in oppo-
site directions by nitric oxide (Shoji et al., 2006a,b) or by cocaine
(Curcio et al., 2013) to tightly regulate D-serine level in glioma
cells and in the nucleus accumbens, respectively.
Divalent cations and phosphorylation at Thr71 by proline-
directed kinases, such as ERK1-2 (Foltyn et al., 2010), are nec-
essary for complete racemase activity. It is noteworthy that the
apoptotic process is associated with an immediate decrease in the
levels of intracellular calcium (Galli et al., 1995) and activated
ERK1-2 (Chin et al., 2004): it is thus reasonable to suppose that
apoptosis may alsomodulate SR activity. Indirect evidence in sup-
port of this hypothesis is the finding that L-serine (1–2mM) can
prevent cell death without activating NMDAR, suggesting that
it is not converted in D-serine in CGNs undergoing apoptosis
(Esposito et al., 2012).
SERINE RACEMASE LEVEL IS INCREASED IN THE LATE PHASE OF
APOPTOSIS AND CONTRIBUTES TO CHANNEL NEURONS TOWARD A
NECROTIC PHENOTYPE
At the biochemical level, one of the most impressive SR changes
is the increase in expression and function at late stages of apopto-
sis. Western blot analysis of cell extracts from apoptotic neurons
showed that SR expression after 48 h was twice that observed at
24 h of apoptosis. SR increase in dying neurons was also con-
firmed by immunofluorescence analysis. Increased SR expression
was positively accompanied by a marked increase in the level of
D-serine in the medium of CGN undergoning apoptosis (K5)
(0.5 ± 0.13μM in control neurons to 10.3 ± 0.7μM in apoptotic
neurons). What are the functional consequences of SR-D-serine
pathway increase in the late phases of apoptosis? It might be the
last, but futile attempt to save neurons from death, providing
new survival signals through the NMDAR. However, the find-
ing that phenazine metasulfate inhibitor of SR activity—added
48 h after inducing apoptosis—reduces the D-serine content and
saves these remaining neurons from death suggests that this late
SR-D-serine increase is toxic to CGNs. Indeed, we found that toxi-
city is blocked by MK801, a noncompetitive NMDAR antagonist,
thus demonstrating that this last wave of cell death is NMDAR-
mediated and of the necrotic or oncotic type. This term is used
to describe cell death that is accompanied by cell swelling and,
eventually, disruption of the cell membrane. The loss of cell mem-
brane integrity results in the release of the cytoplasmic content.
Accordingly, lactate dehydrogenase (LDH) is increased in the
medium of apoptotic neurons in the late phase of apoptosis. LDH
increase is prevented by phenazine metasulfate and MK801, con-
firming that it is triggered by SR increase. Evidence indicates that
necrosis and apoptosis represent morphological expressions of a
shared biochemical network described as the “apoptosis-necrosis
continuum” (Zeiss, 2003). Factors that convert an ongoing apop-
totic process into a necrotic process include a decrease in the
availability of caspases and intracellular ATP (Leist et al., 1999;
Denecker et al., 2001). Secondary necrosis has been reported to
occur as a consequence of: (a) intracellular Ca2+ overload due
to caspase-dependent inactivation of plasma membrane calcium
pumps in CGN undergoing apoptosis by a low dose of gluta-
mate (Schwab et al., 2002); (b) NR2B-mediated cell death due
to accumulation of caspase-3- and calpain-generated N-terminal
tau fragment in CGNs undergoing apoptosis by KCl depriva-
tion (Amadoro et al., 2004, 2006) and (c) proteasome inhibition
(Canu and Calissano, 2006).
Regarding the mechanisms that cause SR to accumulate in the
late phase of apoptosis, we found that increased SR expression
was not dependent on the increased transcription or increased
stability of SR mRNA. As stated above, SR turnover is regulated
by proteasomes in a Golga3-dependent manner. During CGN
apoptosis, UPS and many Golgi-localized proteins became part
of a generalized cellular failure that affects the major activities
of the apoptotic neurons after caspase activation (Canu et al.,
2000; Mancini et al., 2000). Therefore, we can envisage that loss of
Golga3 and UPS impairment causes SR accumulation and death
of neurons in the late stages of apoptosis. This hypothesis is sup-
ported by the finding that cell death caused by pharmacological
inhibition of UPS is prevented by the SR inhibitor phenazine-
metasulfate (Canu et al., unpublished observation). The involve-
ment of NMDAR in cell death induced by UPS inhibition is under
investigation.
SERINE RACEMASE AND NEUROLOGICAL DISORDERS
Proteins of glutamatergic NMDAR signaling pathways have been
studied as targets for intervention in a variety of neuropatho-
logical conditions. D-Serine is now recognized to be involved
in controlling the extent of NMDAR activation and neurotoxic
insults observed in many central nervous disorders (Danysz and
Parsons, 1998).
SCHIZOPHRENIA
Schizophrenia is a long-term mental health condition charac-
terized by a dissociation of various components of the person-
ality. The etiology of schizophrenia involves a combination of
genetic, neurodevelopmental, social, and environmental factors.
The observation that NMDAR antagonists such as phencyclidine
and ketamine were able to induce a psychotomimetic state resem-
bling schizophrenia in human subjects prompted the hypothesis
that NMDAR hypofunction was implicated in the pathophys-
iology of schizophrenia. A deficiency in endogenous D-serine
availability has been proposed to be one of the underlying causes
of NMDAR hypofunction.
Consistent with this hypothesis, several studies have revealed
low levels of SR and low concentrations of D-serine in the serum
and cerebrospinal fluid in subjects with schizophrenia. Moreover,
D-serine reduces negative symptoms and improved cognition in
patients with chronic schizophrenia treated with antipsychotics,
reviewed in Van Horn et al. (2013).
Genetic association studies have implicated genes coding for
enzymes associated with D-serine metabolism in schizophre-
nia. These include single-nucleotide polymorphism variants of
SR, DAAO, and the DAAO interacting protein pLG72, reviewed
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in Labrie and Roder (2010) and Pollegioni and Sacchi (2010).
Remarkably, disrupted in schizophrenia-1 (DISC1), a protein
involved in the pathophysiology of schizophrenia and other psy-
chiatric disorders, directly binds SR, protecting it from ubiquitin-
mediated degradation (Ma et al., 2013). Mutant DISC1 fails to
bind SR, facilitating ubiquitination and degradation of SR and a
decrease in D-serine level production. PICK1, another SR inter-
actor, has also been linked to schizophrenia (Fujii et al., 2006).
Moreover, neonatal inactivation of SR by phenazine methasul-
fate causes behavioral abnormalities in later life. Thus, multiple
risk pathways for schizophrenia may converge on SR depletion
(Balu et al., 2013). This hypothesis is supported by the find-
ing that anatomical deficits in schizophrenia patients—such as
reduced hippocampal volume, decreased dendritic spine den-
sity, altered neuroplasticity likely due to an increase in apoptotic
events (Catts and Weickert, 2012)—are also shared by SR-null
mutant mouse—SR(–/–), a mouse model of NMDAR hypofunc-
tion (Balu et al., 2013). It is worth pointing out, however, that
the morphological deficits found in schizophrenia patients are
the result of a combination of multiple factors, among them the
antipsychotic drugs received. This could account, for example, for
the increased expression of SR found in patients suffering from
schizophrenia and receiving antipsychotic drugs (Verrall et al.,
2007) such as clozapine, which it is known to increase D-serine
release (Tanahashi et al., 2012).
ALZHEIMER DISEASE (AD)
AD is a progressive disease in which dementia symptoms gradu-
ally worsen over a number of years. In its early stages, memory
loss is mild, but with late-stage Alzheimer’s, individuals lose their
ability to carry on a conversation and respond to their environ-
ment. Both reduced expression of NMDAR (Jansen et al., 1990;
Sze et al., 2001) and reduced levels of D-serine have been impli-
cated in NMDAR hypofunction in the early phase of AD (Snyder
and Kim, 2000; Wolosker et al., 2002). D-Cycloserine, a partial
agonist at the glycine site of NMDAR, and the DAAO inhibitor
sodium benzoate were reported in some clinical studies to acti-
vate the NMDAR in brains of AD patients (Chessell et al., 1991;
Lin et al., 2013) and improve their cognitive function (Lin et al.,
2013). Despite these findings, NMDAR activity is supposed to be
increased in moderate to severe AD as memantine, a NMDAR
antagonist, is recommended as an option for managing moderate
and severe AD for patients who cannot be treated with acetyl-
cholinesterase inhibitor (AChEI) (Wilkinson et al., 2013). The
NMDAR activity in the early and late phase of AD may be related
to different regulation of SR expression and may be linked to
different modes of cell death. Indeed, in the early phase of AD,
caspase activity is increased (Ramcharitar et al., 2013) while in
late AD, proteasome impairment and other caspase-independent
mechanisms of cell death occur. The two main hallmarks of AD,
Aβ and tau protein, may alone or in combination perturb the dis-
tribution, the density, and the sensitivity of NMDAR (Ittner et al.,
2010). Nothing is known about the effect of tau-based pathology
of the SR/D-serine pathway. By contrast, Aβ is reported to induce
the release of D-serine and glutamate from cultured microglia,
but not from cultured hippocampal neurons. In particular, Aβ
increases microglial SR transcription (Wu et al., 2004) through
JNK-dependent recruitment of AP-1 complex to SR promoter
(Wu and Barger, 2004).
Conditioned medium from Aβ-treated microglia is toxic to
cultured hippocampal neurons. Toxicity, which tends to manifest
as necrosis, is prevented by the NMDAR glycine site antago-
nist 5,7-dicholorokynurenic acid and by enzymatic degradation
of D-amino acids by DAAO. SR mRNA levels were reported to
be elevated in microglia cultures as well as in AD hippocam-
pus, likely suggesting that it contributes to excitotoxic neuronal
death in severe AD (Wu and Barger, 2004; Wu et al., 2004), as
supported by recent findings that Aβ-induced neurotoxicity is
attenuated in SR knockout mice (Inoue et al., 2008). The form
of pathogenic amyloid (aggregated, oligomeric, or soluble Aβ)
responsible of increased SR expression in AD and why the effect
is specific only for microglia and not for neurons remain to be
established. The following question then arises: is SR modulated
in neurons undergoing apoptosis by Aβ (Troy et al., 2000)?
AMYOTROPHIC LATERAL SCLEROSIS (ALS)
ALS is the most common neuromuscular disease characterized
by dysfunction and death of both upper and lower motoneu-
rons, leading to fatal paralysis. The pathogenesis of this disease
and the reasons for the selective pattern of neurodegeneration
remain uncertain, but mechanisms currently proposed for cell
death in ALS include excitotoxicity and oxidative stress. Patients
with ALS have impaired glutamate transporters and D-serine lev-
els in the spinal cord and motor cortex that could account for
NMDAR overactivation (Sasabe et al., 2012). SR and D-serine
are involved in both the pre-symptomatic and progressive phases
of ALS in G93A Cu, Zn-superoxide dismutase (SOD-1) mice,
the standard model of ALS transgenic mice, suggesting a link
between mutant SOD-1 and D-serine increase in ALS (Sasabe
et al., 2012).
Levels of D-serine and SR in the spinal cords of SOD-1 mutant
mice are progressively elevated, mainly in glia cells as a con-
sequence of pathological activation (Sasabe et al., 2012). ALS
mice with SR deletions show earlier symptom onset, but survive
longer, in an SR-dependent manner. Paradoxically, administra-
tion of D-serine to ALS mice lowers spinal cord levels of D-serine,
leading to changes in onset and survival that are very similar to
SR deletion (Thompson et al., 2012). The mechanism by which
SOD-1mutation increases SR expression and D-serine level is not
known.
Mutant isoform of the SOD1 protein impairs UPS func-
tion (Kabashi et al., 2004)—likely by decreasing constitutive
proteasome—and increases SR expression when overexpressed
in microglia cells (Sasabe et al., 2012). Given that both SR
and pLG72, the DAAO-interacting partner (Sacchi et al., 2008),
are regulated by the proteasome system (Dumin et al., 2006;
Cappelletti et al., 2014), it is tempting to speculate that pro-
teasome impairment in SOD-1 mutated mice increases both
SR and pLG72 protein expression, conditions which result in
high levels of D-serine and consequently in NMDAR overacti-
vation. Alternatively, increased expression of SR may result from
increased transcription in microglia activated by cytokines, which
are strongly induced in spinal cord of G93A-SOD1 mice (Hensley
et al., 2002)
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Other neurodegenerative diseases, such as PD and HD, have
been associated with altered NMDAR activity. It has been sug-
gested that NMDAR stimulation, accomplished through allosteric
modulation via the glycine modulatory site may be beneficial in
late-phase PD. Indeed, preliminary findings suggest that D-serine
treatment, in addition to usual medications, may be beneficial in
PD, resulting in increased D-serine serum levels and in improv-
ing motor deficits (Gelfin et al., 2012; Heresco-Levy et al., 2013).
However, little is known about how and if D-serine content or
SR and DAAO activities are modulated in PD. Similarly, our
knowledge on SR/D-serine pathway is more scarce or absent for
HD (a neurodegenerative genetic disorder that affects muscle
coordination and leads to cognitive decline and psychiatric prob-
lems), where cell death has been linked to abnormally enhanced
NMDAR activity (Marco et al., 2013).
EPILEPSY
Temporal lobe epilepsy is associated with various cognitive
changes, but the mechanisms underlying these changes are
unknown. It has been recently reported that D-serine deficiency
is important in the amnestic symptoms of temporal lobe epilepsy
(Klatte et al., 2013). Indeed, this condition in rats is associ-
ated with a reduction in D-serine levels in the central nervous
system, which leads to a desaturation of the coagonist binding
site of synaptic and extrasynaptic NMDARs. NMDAR desatura-
tion causes a deficit in hippocampal LTP, which can be rescued
with exogenously supplied D-serine. For example, added, exoge-
nous D-serine improved spatial learning in epileptic animals
(Klatte et al., 2013). It is worthy of note that D-serine decline is
linked to decreased expression of SR—at both mRNA and pro-
tein levels—in the hippocampal CA1 region and to increased
expression of mRNA for DAAO (Klatte et al., 2013). This find-
ing is similar to the changes observed in neuronal apoptosis
(Esposito et al., 2012), in aging (Mothet et al., 2006; Turpin
et al., 2011), and in the nucleus accumbes of cocaine-treated
rats (Curcio et al., 2013), suggesting that apoptotic mechanisms
may determine SR/D-serine pathway changes in epilepsy. This
result is supported by findings that neuronal death, which has
been implicated as a causal factor in epileptogenesis, is con-
trolled by apoptosis-associated molecular mechanisms, reviewed
in Henshall and Engel (2013).
STROKE AND ISCHEMIA
Neuronal damage resulting from overactivation of NMDA recep-
tors contributes to acute disorders such as ischemia and trauma
that are prevented by agents blocking NMDAR activity, such
as memantine. High levels of D-serine have been observed in
simulated (oxygen/glucose deprivation, OGD) ischemia mod-
els, causing neuronal death (Katsuki et al., 2004). Evidence
for a central role of D-serine synthesis from L-serine by SR
during OGD was given in SR knockout mice, displaying 90%
reduced D-serine concentrations and decreased neurotoxicity
and dramatically diminished infarct volume after middle cere-
bral artery occlusion (MCAO) (Mustafa et al., 2010). These
changes are accompanied by marked declines in NO forma-
tion and nitrosylation of its targets. Interestingly the pro-
nounced reduction in infarct volume of SR knockout animals
following MCAO is comparable to protection against stroke
damage associated with pharmacologic blockade of NMDA
receptors. Since no increase in SR expression (but rather
a decrease in SR expression was observed during the first
12 h of ischemic insult) or decrease in DAAO expression was
observed in different models of ischemia, it is reasonable to
suppose that increased levels of D-serine may result from
increased SR activity (likely as a consequence of phosphory-
lation, changes in intracellular distribution, and/or change in
binding partners), decreased DAAO activity, altered shuttling of
D-serine across membranes, and or altered NR1 expression and
sensitivity.
CONCLUSIONS
Extensive research in the past 30 years has shed molecular light
onto the mechanisms linking NMDAR physiology and patho-
physiology to neuronal survival/plasticity and to neuronal dis-
eases (such as acute stroke, neuropsichiatric disease, and neu-
rodegenerative disorders), respectively. Although we have already
discovered several important targets that play important roles in
mediating NMDAR activity, the present challenge is to develop
novel compounds that will be selective for the excitotoxic or
pro-survival effects of NMDAR stimulation.
The development of such compounds must deeply rely on the
complex mechanisms and pathways of neuronal demise (trig-
gered by lack of survival signals or by toxic insults), which,
as widely stated in this review, often implies the interplay and
shift of different modes of cell death (e.g., apoptosis/necrosis or
necrosis/apoptosis shift) (Jellinger, 2001; Andorfer et al., 2005;
Canu et al., 2005). On the other hand, our understanding of
the complexity of the mechanisms that governs cell death is also
currently evolving with the identification of novel key regula-
tors of this process. In the present review we highlighted new
findings showing the importance of the dual and opposite role
of the SR/D-serine pathway in the fine regulation of neuronal
apoptosis and the apoptosis/necrosis shift (Esposito et al., 2012)
both in “in vitro” and “in vivo” conditions. Many questions
still remain regarding how the cell death process influences—
via transcriptional and/or post-transcriptional (phosphoryla-
tion) mechanisms—SR activity and also other components of
the D-serine pathway. The answer to these questions, and in
particular to post-transcriptional mechanisms involved in SR
activity during different stages of apoptosis (such as phosphory-
lation, nitrosylation, etc.), might have implications for a deeper
understanding of the conformational plasticity underlying SR
response to physiological effectors and to potential therapeutic
agents.
Moreover, special attention should be paid in the future to
the involvement and modulation of other components of the
D-serine pathway (e.g., DAAO, D- and L-serine transporters) in
the cell death process and NMDAR activity, in light of recent
findings on the contribution of D-serine transporters (through
the release of D-serine) to synaptic NMDAR activity (Rosenberg
et al., 2013). Similarly, the role of L-serine transporters in the
supply of L-serine to neurons by astrocytes for the synthesis
of D-serine by serine racemase (Ehmsen et al., 2013) is also
important.
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